Articles

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hucthinson Cancer Research Center, Univ of Washington, VA Puget Sound Health Care, Seattle, USA;
Stanford University, Palo Alto, CA, USA;
University of Leipzig, Leipzig, Germany;
Colorado Blood Cancer Institute at HealthONE Presbyterian/St. Luke Medical Center, Denver, USA;
University of Utah, Salt Lake City, UT, USA;
Azienda Ospedaliera S Giovanni Battista, University of Turin, Turin, Italy;
City of Hope/Kaiser Permanente Medical Group, Duarte, CA, USA;
Winship Cancer Institute at Emory University, Atlanta, GA, USA;
Medical College of Wisconsin, Milwaukee, WI, USA;
Baylor University, Dallas, TX, USA;
University of Copenhagen Rigshospitalet, Copenhagen, Denmark;
Oregon Health and Science University, Portland, OR, USA;
Medical Center University of Tübingen, Tübingen, Germany;
LDS Hospital, Salt Lake City, UT, USA;
University of Colorado, Denver, CO, USA;
Aarhus University, Aarhus, Denmark;
University of Arizona Cancer Center, Tucson, AZ, USA;
University Hospital of Cologne, Cologne, Germany;
Mayo Clinic, Rochester, MN, USA
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA;
Haematologica Early view Jun 4, 2020 https://doi.org/10.3324/haematol.2020.248187